Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Toxicol Appl Pharmacol ; 172(3): 163-71, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11312643

ABSTRACT

Pituitary status has a significant effect on the expression of several cytochrome P450 enzymes. The goal of this study was to examine the role of pituitary input on the modulation of CYP2C11 and CYP2B after treatment with the aromatic hydrocarbon ethylbenzene (EB). Intact, hypophysectomized (HX), and HX rats supplemented with pulsatile growth hormone (GH) were treated with corn oil or EB and the effects on hepatic P450 expression were determined. Hypophysectomy caused a 50% decrease in CYP2C11 protein in untreated rats, whereas GH supplementation returned protein to control levels. EB administration also decreased CYP2C11 protein in intact rats; however, this decrease was not observed after EB treatment in HX or HX + GH groups. CYP2C11-dependent testosterone 2alpha-hydroxylation followed a similar pattern as CYP2C11 protein, except that the activity was only partially restored by GH replacement. CYP2B levels were also substantially influenced by hypophysectomy. Intact rats exhibited a 100-fold increase in CYP2B1 mRNA, reaching a maximum 12 h after EB administration. A much smaller response (ca. 20-fold) was observed in HX rats, reaching a maximum 24 h after EB treatment. This effect was not reversed by GH supplementation. The half-life for EB was significantly increased from 8 h in intact rats to 14 h in HX rats, suggesting higher plasma EB concentrations after EB administration to HX rats. These results indicate that CYP2C11 and CYP2B become less responsive to EB-dependent modulation in HX rats, a response that cannot be explained simply by absence of GH or by altered EB pharmacokinetics in HX animals.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Benzene Derivatives/pharmacology , Cytochrome P-450 Enzyme System/genetics , Gene Expression/drug effects , Growth Hormone/administration & dosage , Hypophysectomy , Steroid 16-alpha-Hydroxylase , Animals , Benzene Derivatives/toxicity , Cytochrome P-450 CYP2B6 , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Enzyme System/metabolism , Cytochrome P450 Family 2 , Enzyme Induction/drug effects , Enzyme Inhibitors/pharmacology , Kinetics , Male , Oxidoreductases, N-Demethylating/genetics , Periodicity , Pituitary Gland/physiology , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , Rats , Steroid Hydroxylases/antagonists & inhibitors , Steroid Hydroxylases/genetics , Steroid Hydroxylases/metabolism
2.
Mol Cell Endocrinol ; 150(1-2): 179-87, 1999 Apr 25.
Article in English | MEDLINE | ID: mdl-10411312

ABSTRACT

The ability of bisphenol A (BPA) to affect human estrogen receptor (ER) binding, expression of progesterone receptor (PR) mRNA and protein, and cell proliferation has been measured in the human endometrial cell line, ECC-1. Although less potent than 17beta-estradiol, BPA was able to bind to the human uterine ER. BPA also induced both mRNA and protein to levels similar to E2. BPA-mediated PR mRNA induction was antagonized by ICI, suggesting an ER-mediated pathway. Finally, E2 produced a 2-fold increase in cell number, while BPA showed no difference compared with vehicle control. The increase by E2 was inhibited by treatment with the either ICI 182,780 (ICI) or BPA, suggesting similar binding sites. Although ER binding is similar, E2 affected both proliferation and PR expression, while BPA only affected PR gene expression. The results of this study provide evidence that two ER agonists can act differentially in vitro to affect the expression of genes involved in regulating cellular growth and development, though the human risk potential remains to be determined.


Subject(s)
Carcinoma/metabolism , Endometrial Neoplasms/metabolism , Estrogens, Non-Steroidal/pharmacology , Phenols/pharmacology , Receptors, Estrogen/metabolism , Receptors, Progesterone/biosynthesis , Benzhydryl Compounds , Binding, Competitive , Carcinoma/pathology , Cell Division/drug effects , Endometrial Neoplasms/pathology , Estradiol/pharmacology , Estrogens, Non-Steroidal/metabolism , Female , Humans , Phenols/metabolism , RNA, Messenger/biosynthesis , Tumor Cells, Cultured
3.
Toxicol Appl Pharmacol ; 157(1): 1-8, 1999 May 15.
Article in English | MEDLINE | ID: mdl-10329501

ABSTRACT

Treatment of rats with ethylbenzene (EB) modulates the hepatic expression of many P450s, with those induced after a single intraperitoneal hydrocarbon injection differing from those induced after more prolonged (3 day) administration. The goals of the current studies are (1) to characterize the induction response after prolonged hydrocarbon exposure, (2) to explain why the elevation of these P450s is attenuated after continued treatment, and (3) to determine how P450 2B protein remains elevated without an elevation of P450 2B1/2 RNA. P450 2C11 protein was decreased after a single EB injection and remained depressed throughout the treatment period. P450 2C11 RNA was only decreased with prolonged, but not acute treatment. P450 2E1 was induced after a single EB injection; however, the initial induction was attenuated with more prolonged treatment. P450 2B1 and P450 2B2 RNAs exhibited a similar response, being elevated after acute administration, but returned to control levels with prolonged EB administration. Interestingly, P450 2B protein levels remained elevated despite the decrease in P450 2B1 and P450 2B2 RNA to control levels. We then tested the possibility that the multiphasic induction pattern of P450 2E1 and P450 2B1/2 RNA was due to differences in the pharmacokinetics of EB. The disappearance of EB with time was measured in rats that were either (1) untreated, (2) pretreated with EB for 1 day, or (3) pretreated with EB for 3 days. These results demonstrated that prior hydrocarbon exposure caused an increase in EB clearance, which decreased the overall levels of EB in the body. Consequently, EB levels were sufficiently diminished to decrease EB's effectiveness as an inducer leading to the decrease in P450 2E1 protein and P450 2B1 and P450 2B2 RNA after continued EB administration. A further consequence of the decreased overall EB concentration is that the hydrocarbon was capable of producing only a transient elevation of P450 2B1 RNA levels. This transient elevation appears to be sufficient to maintain elevated P450 2B protein.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Benzene Derivatives/toxicity , Cytochrome P-450 CYP2B1/biosynthesis , Cytochrome P-450 CYP2E1/biosynthesis , Cytochrome P-450 Enzyme System/biosynthesis , Steroid 16-alpha-Hydroxylase , Steroid Hydroxylases/biosynthesis , Animals , Benzene Derivatives/pharmacokinetics , Cytochrome P-450 CYP2B1/genetics , Cytochrome P-450 CYP2E1/genetics , Cytochrome P-450 Enzyme System/genetics , Enzyme Induction/drug effects , Male , RNA, Messenger/analysis , Rats , Steroid Hydroxylases/genetics
4.
Xenobiotica ; 28(3): 303-12, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9574818

ABSTRACT

1. The aim was to determine if the ethylbenzene (EB)-mediated expression of CYP2B and CYP2C11 involved a hormonally controlled component. 2. The hypophysectomized (HX) and intact rats were treated with EB for 1 or 2 days, and the effects on specific CYP levels measured. 3. Differences were observed in the inducibility of CYP2B by EB in the HX rat when compared with intact controls. Whereas significant elevations of CYP2B-dependent activities and protein levels were observed after both 1 and 2 days of EB injection in intact controls, CYP2B levels were significantly elevated in the HX rat only after 2 days of hydrocarbon treatment. 4. Both CYP2C11-dependent activities and protein levels were decreased after EB administration to the intact rat. In contrast, CYP2C11 levels were unaffected by EB in the HX rat at any of the time points indicated. 5. CYP2C11 protein levels were unaffected by treatment with EB for 24 h in cultured hepatocytes, also supporting the hypothesis that hormones are involved in CYP2C11 expression. 6. This study indicates that pituitary input influences the EB-mediated changes in both CYP2B and CYP2C11. CYP2C11 is affected by EB administration in a manner similar to other xenobiotics such as phenobarbital. On the other hand, the smaller induction of CYP2B1/2 in response to EB differs from that observed with phenobarbital where HX augmented the response of the inducer.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Benzene Derivatives/pharmacology , Cytochrome P-450 Enzyme System/biosynthesis , Liver/enzymology , Peptidylprolyl Isomerase/biosynthesis , Pituitary Gland/metabolism , Steroid 16-alpha-Hydroxylase , Steroid Hydroxylases/biosynthesis , Animals , Cytochrome P-450 Enzyme System/chemistry , Cytochrome P450 Family 2 , Gene Expression Regulation, Enzymologic/drug effects , Hypophysectomy , Rats
5.
Sante Ment Que ; 11(2): 37-9, 1986.
Article in French | MEDLINE | ID: mdl-17093545

ABSTRACT

In this short article, the authors give an historical view of the Balint Group. They then explain its beginning, in Quebec, specifically at the Citizens Clinic in St.Jacques, Montreal. Those groups are mainly involved in developing feelings of intensity and unicity.

SELECTION OF CITATIONS
SEARCH DETAIL
...